Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists.
Jessica DaherAntoine Da CostaChristophe HilaireThomas FerreiraRomain PierrardJean Baptiste GuichardCécile RomeyerKarl IsaazPublished in: Clinical drug investigation (2020)
This retrospective observational study found a similar efficacy between DOAC and VKA agents in patients with LV thrombi (70.6% vs. 71.5%); however, when the thrombus remains, VKAs are still the standard of care as it is possible to control INR levels (3-4) with them.
Keyphrases
- direct oral anticoagulants
- venous thromboembolism
- atrial fibrillation
- left ventricular
- cross sectional
- healthcare
- palliative care
- heart failure
- left atrial
- quality improvement
- acute myocardial infarction
- hypertrophic cardiomyopathy
- mitral valve
- cardiac resynchronization therapy
- pain management
- coronary artery disease
- chronic pain
- acute coronary syndrome
- catheter ablation